Cargando…
Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds
Traumatic brain injury is common, and often results in debilitating consequences. Even mild traumatic brain injury leaves approximately 20% of patients with symptoms that persist for months. Despite great clinical need there are currently no approved pharmaceutical interventions that improve outcome...
Autores principales: | Lins, Brittney R., Anyaegbu, Chidozie C., Hellewell, Sarah C., Papini, Melissa, McGonigle, Terence, De Prato, Luca, Shales, Matthew, Fitzgerald, Melinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026409/ https://www.ncbi.nlm.nih.gov/pubmed/36935484 http://dx.doi.org/10.1186/s12974-023-02734-9 |
Ejemplares similares
-
Plasma Lipid Profiles Change with Increasing Numbers of Mild Traumatic Brain Injuries in Rats
por: Anyaegbu, Chidozie C., et al.
Publicado: (2022) -
Cuprizone feed formulation influences the extent of demyelinating disease pathology
por: Toomey, Lillian M., et al.
Publicado: (2021) -
Secondary Degeneration Impairs Myelin Ultrastructural Development in Adulthood following Adolescent Neurotrauma in the Rat Optic Nerve
por: Lins, Brittney R., et al.
Publicado: (2023) -
Secondary Degeneration of Oligodendrocyte Precursor Cells Occurs as Early as 24 h after Optic Nerve Injury in Rats
por: Toomey, Lillian M., et al.
Publicado: (2023) -
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
por: Kokona, Despina, et al.
Publicado: (2016)